127 related articles for article (PubMed ID: 19690760)
1. P53, p63 and Ki-67 assessment in HPV-induced cervical neoplasia.
Vasilescu F; Ceauşu M; Tănase C; Stănculescu R; Vlădescu T; Ceauşu Z
Rom J Morphol Embryol; 2009; 50(3):357-61. PubMed ID: 19690760
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
Horikoshi M; Kina K; Ishi K; Izumi H; Kunii Y; Nojima M
Rinsho Byori; 2005 Jun; 53(6):494-8. PubMed ID: 16026074
[TBL] [Abstract][Full Text] [Related]
3. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
5. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
6. [Infection of human papillomavirus 16/18 DNA in patients with head and neck squamous cell carcinoma and its relationship with expression of Ki-67 and P53 protein].
Zhang JL; Sun Z; Huo Z; Luo YF; Ma SQ; Wang DT; Cao JL; Yang T; Cui QC; Bai CM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):429-32. PubMed ID: 20868604
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
[TBL] [Abstract][Full Text] [Related]
8. p63 immunostaining in destained bronchoscopic cytological specimens.
Shtilbans V; Szporn AH; Wu M; Burstein DE
Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma.
Wu M; Kafanas A; Gan L; Kohtz DS; Zhang L; Genden E; Burstein DE
Diagn Cytopathol; 2008 Nov; 36(11):797-800. PubMed ID: 18831009
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
12. Adenoid basal carcinomas of the cervix: a unique morphological evolution with cell cycle correlates.
Cviko A; Briem B; Granter SR; Pinto AP; Wang TY; Yang YC; Chen BF; Yang A; Sheets EE; McKeon FD; Crum CP
Hum Pathol; 2000 Jun; 31(6):740-4. PubMed ID: 10872669
[TBL] [Abstract][Full Text] [Related]
13. [Ki-67 expression as a predictor of the effectiveness of radiotherapy and of outcome in locally advanced squamous cell carcinoma of the uterine cervix (immunohistochemical study)].
Kuznetsova ME; Pozharisskiĭ KM; Vinokurova VL; Zharinov GM; Neklasova NIu
Vopr Onkol; 2007; 53(2):175-80. PubMed ID: 17663171
[TBL] [Abstract][Full Text] [Related]
14. Proliferation in squamous cell carcinoma of cervix: a comparative assessment by two markers.
Pahuja S; Choudhury M; Gupta U
Indian J Pathol Microbiol; 2003 Oct; 46(4):585-8. PubMed ID: 15025349
[TBL] [Abstract][Full Text] [Related]
15. Effect of p63 expression on survival in oral squamous cell carcinoma.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma.
Oliveira LR; Ribeiro-Silva A; Zucoloto S
Acta Histochem; 2007; 109(5):388-96. PubMed ID: 17499344
[TBL] [Abstract][Full Text] [Related]
18. p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.
Malisic E; Jankovic R; Majkic M; Dobricic J; Radulovic S
J BUON; 2008; 13(4):525-32. PubMed ID: 19145674
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers.
Kedzia W; Schmidt M; Frankowski A; Spaczyński M
Folia Histochem Cytobiol; 2002; 40(1):37-41. PubMed ID: 11885807
[TBL] [Abstract][Full Text] [Related]
20. Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression.
Ancuţa E; Ancuţa C; Cozma LG; Iordache C; Anghelache-Lupaşcu I; Anton E; Carasevici E; Chirieac R
Rom J Morphol Embryol; 2009; 50(3):413-8. PubMed ID: 19690767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
